Pharmesis International Ltd. (SGX:BFK)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.310
+0.010 (3.33%)
At close: Feb 19, 2026
-42.06%
Market Cap 9.83M
Revenue (ttm) 12.62M
Net Income (ttm) 1.85M
Shares Out 31.70M
EPS (ttm) 0.06
PE Ratio 5.32
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 33,400
Average Volume 10,560
Open 0.310
Previous Close 0.300
Day's Range 0.310 - 0.310
52-Week Range 0.200 - 0.605
Beta -1.19
RSI 40.06
Earnings Date Feb 27, 2026

About Pharmesis International

Pharmesis International Ltd., an investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China. The company provides prescribed products and over-the-counter drugs. It offers western medicine products under the Kinna brand, including Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Compound Procaine hydrochloride to treat arterioscler... [Read more]

Industry Pharmaceutical Preparations
Founded 1996
Employees 1,096
Stock Exchange Singapore Exchange
Ticker Symbol BFK
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.